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Abstract 
Drug permeation through skin from topical nanoemulsion (NE) depends on the 
concentration of the oil phase, aqueous phase, surfactant and co surfactant. Hence it is very 
important in optimizing the composition of NE. The conventional method of experimentation 
is costlier and is restricted to changing one factor at a time, the other factors being kept 
constant. Hence, there is a need of design of experiment (DoE), a statistical tool for finding 
optimum combination, using relationship between factors affecting a process and output of 
that process. The levels of the critical factors influencing the NE formation, were obtained 
from pseudo ternary phase diagram. From the design matrix of DoE, formulation matrix was 
generated which were analyzed for globule size as response. The model was found to be 
highly significant from the F ratio (71.49) and R2 value of 0.9940. The optimized formulation 
was found to pass the stability and viscosity test (approx.120 cP). Ex-vivo skin permeation 
test of nanoemulgel (NG) formulation showed skin permeability of approximately 20% of the 
drug, while the marketed cream (MC) showed a permeability of 18% only. The amount of 
drug retained in the skin by the NG formulation was found to be approximately 31% while 
for the MC it was found to be only 20%. The NG formulation was found to treat the infected 
rat skin within 12 days of treatment while the MC took about 16 days for complete removal 
of the infection. Thus the NG formulation effectively permeates to the layers of the skin and 
treats the fungal infection more effiently than the MC.      
 
Keywords: Nanoemulsion, design of experiment, ex-vivo skin permeation tests, in-vivo 
treatment of infected skin 
 
Introduction  
Topical preparations are those formulations meant for application to the surface of the 
skin for localized effect to treat various skin infections, as pain releaving medications 
etc.,.(1). Dermatophytes, in the evolutionary process have acquired the ability to metabolize 
and subsist upon keratin, a protein resistant to most other organisms (2). The fungi attack 
skin, nails, and hair, where keratin is the major structural protein, leading to a wide variety of 
disease states. Three types of dermatophytes account for the majority of infections: 
Epidermophyton, Trichophyton, and Microsporum. Dermatophytoses have varied 
presentations, are named by location, and have similar treatments. The major types of 
dermatophyte infections include: involvement of the scalp (tinea capitis), feet (tinea pedis), 
groin (tinea cruris), and other body surfaces (tinea corporis). These are typically superficial, 
involving the epidermis (2,3). The conventional topical agents like creams, ointments, lotions 
pose many disadvantages . They are  sticky causing uneasiness when applied, have less 
spreading coefficient, exhibit stability problems also. Nano emulsions are  heterogenous, 
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isotropic, thermodynamically stable, transparent systems, where the dispersions of oil and 
water are stabilized by use of surfactant molecules (4).  
Drug permeation through skin from topical nanoemulsion formulations depends on 
their composition of the oil phase, aqueous phase, surfactant and co surfactant. Hence it is 
very important in optimizing the composition of these 4 factors in the formulation of 
nanoemulsion (5). The conventional method of experimentation is costlier and is restricted to 
changing one factor at a time, the other factors being kept constant. This fails to show 
interaction effect that may exist between some of the factors consequent on which optimum 
combinations are difficult to be determined. Hence, there is a need of design of experiment 
(DoE), a statistical tool for finding optimum combination, using relationship between factors 
affecting a process and output of that process (6).  
Butenafine is a synthetic benzylamine derivative used for the topical treatment of 
tinea pedis. It works by inhibiting the synthesis of ergosterol by inhibiting squalene 
epoxidase, an enzyme responsible for the creation of sterols needed in fungal cell membranes 
(7). Lacking ergosterol, the cell membranes increase in permeability, allowing their contents 
to leak out. Though the marketed formulations effectively treat the fungal infection they 
require prolonged used of the drug. The present work is aimed at formulating nanoemulgel of 
butenafine hcl, with increased permeability and thus reduce the duration of treatment.   
 
Materials  
Butenafine Hcl was obtained as a gift sample from Vasista laboratories (Hyderabad, 
India). Capryol 90, Capmul MCM, Labrafac (LF), Isopropyl myristate (IPM), Lauroglycol 
(LG), Labrafac Lipophile (LL) and Soya oil (SO) were received as a gift sample from 
Gattefosse Pvt. Ltd. (Mumbai, India). Cremophore RH 40 was obtained as gift samples from 
Gattefosse (Mumbai, India). Ethanol was purchase from Rankem Pvt. Ltd. Carbopol 934P 
was purchased from Corel Pharma (Ahmedabad, India). T. rubrum (MTCC No. 296) and C. 
albicans (MTCC No.3018) were procured from Institute of Microbial Technology 
(Chandigarh, India).Double distilled water was used throughout the study. All other chemical 
reagents and solvents used were of analytical grade. 
 
Method  
Nanoemulsion was formulated by spontaneous emulsification technique using slow 
aqueous titration method and is dispersed into the carbapol gel (8). 
 
Solubility studies (9) 
Solubility of Terbinafine was determined in various oils such as Capryol 90, Capmul 
MCM, LF, IPM, LG, LL, and SO by shake flask method. An excess amount of drug was 
taken in 2 ml of the oil in vials, and mixed using vortex mixer. The vials were then kept at 25 
± 10C in an isothermal shaker for 72hrs to reach equilibrium. The equilibrated samples were 
then centrifuged at 3,500rpm for 15min. The supernatant was filtered through a 0.45μm 
membrane filter. The amount of drug dissolved in the oil was determined using UV 
spectrophotometer at their respective wavelength (table 1). 
 
Construction of pseudoternary phase diagram (10) 
Pseudo ternary phase diagrams were constructed to examine the formation of oil in 
water nanoemulsion with 4 components oil, surfactant, cosurfactant, and aqueous phase. The 
4-component system consists of (i) Labrafac Lipophile (Selected from solubility studies) (ii) 
surfactant Cremophore RH40 (iii) a Cosurfactant (Ethanol) and (iv) distilled water (aqueous 
phase). Surfactant and cosurfactant in each group were mixed in different weight ratios (1:1 
to 1:9 and 1:1 to 9:1). These ratios were choosen in increasing concentration of surfactant 
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with respect to co surfactant and viceversa. For each phase diagram, oil and specific 
surfactant and co surfactant mixture (ScoS) was mixed in different weight ratios freom 1:9 to 
9:1 in different glass vails. Seventeen combinations of oil and SCoS, 1:9, 1:8, 1:7, 1:6, 1:5, 
1:4, 1:3, 1:2, 1:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1 , 2:1 were made so that maximum ratios were 
covered for the study to depict the boundaries of phases precisely formed in the phase 
diagrams Slow titration with aqueous phase was done to each weight ratio of oil and SCoS 
and visual observation was carried out for transparency and flowability of the nanoemulsions. 
Only the nanoemulsion regions were plotted in the pseudoternary phase diagram. The 
pseudo-ternary phase diagrams were built using CHEMIX School software ( fig 1 to 6). 
 
Fig 1: ScoS 2:1                                            Fig 2: ScoS 2:3 
 
Fig 3: ScoS 3:2                                                        Fig ScoS  4:1 
 
Fig 5: ScoS 5:2                                       Fig 6 : ScoS 6:3 
 
4.3 23 Factorial design (11) 
Full factorial design allows studying the effect of each factor on the response variable, 
as well as the effects of interactions between factors on the response variable. The minimum 
and maximum levels of the independent variables were obtained from the pseudo ternary 
phase diagrams and are incorporated in the DoE design matrix (table 2). The optimized 
formulation of the nanoemulsion was achieved by analysis of the results of the design matrix 
using UNSCRAMBLER 10.3X software, with three critical factors which influence globule 
size of the nanoemulsion (table 3).  
European Scientific Journal   December 2013 /SPECIAL/ edition vol.4  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
 
 600 
The batches were formulated and evaluated for globule size of the emulsion and the 
design matrix was analysed (table 4). Three batches of the optimized formulation (A, B, C) as 
given by the results of DoE were prepared and stability studies were performed. 
 
Thermodynamic Stability studies (9) 
The batches A, B and C were formulated with the optimized composition of SCoS 2:1 
and Oil:SCoS 1:1 and were subjected to different thermodynamic stability studies such as 
centrifugation, heating cooling cycle and freeze thaw cycle, to avoid the selection of 
metastable formulations (table 5).  
 
Incorporation of drug 
Stable and optimized nanoemulsion formulations from stability studies were selected 
and formulated by incorporating the drug in the oil phase such that it accounts to 1% of the 
total nanoemulgel.  
 
Preparation of gel 
4% Carbapol gel was prepared using 10% Triethanolamine and the pH was adjusted to 7.2. 
 
Incorporation of nanoemulsion into the gel 
The nanoemulsion was incorporated into the gel by simple dispersion.  
 
Evaluation of nanoemulgel 
Thus the formulated nanoemulgel is evaluated for viscosity (12) (table 6) using 
Brookfield DV III ultra V6.0 RV cone and plate rheometer using spindle # CPE40 at 
25±0.50C, homogeneity by visual characterization, ex-vivo drug permeation through skin 
using Franz diffusion cell, and in vivo treatment of infected rat skin. 
 
Ex-vivo drug permeation through rat skin using Franz diffusion cell (13): 
Ex-vivo skin permeation studies for formulation A, B and C, marketed formulation 
and a blank were performed in a Franz diffusion cell with a diffusion area of 2.26cm2 and 
receptor volume of 22.5mL using abdominal rat skin. Abdominal rat skin was excised and 
washed with isotonic NaCl. The excised skin was then mounted between the donor and the 
receptor chambers of the Franz diffusion cell with the dermal side in contact with the receptor 
medium and the stratum corneum side facing upwards into the donor compartment. Then, 
optimized NE formulation equivalent to 250 mg of Butenafine Hcl was evenly applied on the 
surface of the rat skin in the donor compartment. The receptor compartment was filled with 
physiological saline solution (pH 5.5 acetate buffer/methanol (9:1)). The temperature in the 
receptor compartment was maintained at 37±0.5 °C to simulate the skin temperature and was 
magnetically stirred at 50 rpm. Samples were withdrawn at predetermined time intervals of 
0.15, 0.30, 0.45, 1, 2, 4, 6, and 9hrs, filtered through 0.45µm cellulose membrane filter and 
analyzed for butenafine content by UV spectroscopy (fig 7). Fresh buffer solution was 
immediately replaced into the receptor chamber after each sampling. 
After 9hrs the % drug retained on the skin at the end of 9th hr was determined. The rat 
skin is minced, equilibrated with physiological buffer solution to extract the drug from the 
skin layers. The equilibrated solution is filtered through 0.22µm filter and was analyzed for 
drug content spectrophotometrically. 
 
Infecting the rat skin (14) 
12 male wistar rats, each weighing 180 to 200gms were selected with 3 in each group. 
One   group for formulation A, the other for formulatio B , the third for marketed formulation 
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and the fourth group is maintained as control. On the back of each animal, the areas of 4 cm  
were cleaned and depilated. The infectious inoculum was prepared from a 7 day old culture 
of Trychophyton mentagrophytes. The inoculum was applied on the animal back immediately 
after the depilation and left for 7 days. The establishment of active infection was confirmed 
by visual examination of the erythematous lesions.  
 
In vivo treatment of infected rat skin 
To the infected area the formulated gel was applied and the animals were kept 
undisturbed for 24hrs. They were examined for the disappearance of the lesions and this 
procedure was repeated until complete disappearance of the lesions. 
 
Results and discussion 
Solubility studies 
Solubility of the drug in the oil phase plays a crucial role in the formulation of 
nanoemulsion. So the oil in which the drug shows maximum solubility is selected for further 
studies. From table 1 it shows that Labrafac lipophile shows maximum drug solubility of 
127mg/mL. Hence LL is selected as the oil phase for nanoemulsion formulation. 
Table 1: Solubility studies 
OIL SOLUBILITY(mg/mL) 
CAPRYOL 90 48 
CAPMUL MCM 27 
LF 62 
IPM 21 
LG 34 
LL 127 
SO 40 
 
Pseudo ternary phase diagram study 
Phase behavioral studies were performed by constructing phase diagrams that depict 
the boundaries of different phases, as a function of composition and temperature, to 
investigate the structural organization of the emulsions formed. The concentration of 
surfactant and co-surfactant is responsible for the barrier formation at the interface required 
to prevent the coalescence of the formed nanoemulsion. SCoS gets adsorbed at the interface, 
reducing the energy required for nanoemulsion formation thus improving the thermodynamic 
stability of the nanoemulsion formulation. From the pseudoternary phase diagram study, it is 
evident that the oil concentration of 1 to 5mL and surafcatant concentrationof 2 to 6 mL and 
cosurfactant concentration of 1 to 3 promotes the nanoemulsion region with required 
consistancy. Hence these limits were inserted in the design matrix and analysed for optimized 
formulation. 
Table 2: Variables for optimization and their limits 
INDEPENDENT VARIABLES LEVELS 
LOW HIGH 
SL.NO VARIABLE UNIT -1 +1 
1 OIL mL 1 5 
2 CREMOPHORE RH 40 mL 2 6 
3 ETHANOL mL 1 3 
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Table 3: Variable optimization using DoE: Matrix generated by UNSCRAMBLER 10.3 X software and the 
response values 
STD RUN BATCH FACTOR 1,     
OIL (mL) 
FACTOR 2, 
CREMOPHORE 
RH 40 (mL) 
FACTOR 3, 
ETHANOL (mL) 
GLOBULE 
SIZE (nm) 
1 9 F1 1 2 1 40 
2 2 F2 5 2 1 25 
3 3 F3 1 6 1 18 
4 4 F4 5 6 1 12 
5 10 F5 1 2 3 56 
6 1 F6 5 2 3 60 
7 6 F7 1 6 3 20 
8 11 F8 5 6 3 60 
9 5 F9 3 4 2 15 
10 7 F10 3 4 2 32 
11 8 F11 3 4 2 28 
 
Table 4: ANOVA results of DoE 
ANOVA SS  DF MS F-RATIO p-VALUE 
SUMMARY      
MODEL 1113.5 7.0 159.0714 71.4198 0.0025 
ERROR 6.6818 3.0 2.2273   
CORRECTED TOTAL 1120.1820 10.0    
VARIABLES      
OIL(A) 578.0 1.0 578.0 259.5102 0.0005 
CREMOPHORE RH 40 (B) 480.0 1.0 480.5 215.7347 0.0007 
ETHANOL (C) 50.0 1.0 50.0 22.4490 0.0178 
OIL*CREMOPHORE RH 40 2.0 1.0 2.0 0.8980 0.4132 
OIL* ETHANOL 0.5 1.0 0.5 0.2245 0.6680 
CREMOPHORE RH 40 * 
ETHANOL 
2.0 1.0 2.0 0.8980 0.4132 
OIL*CREMOPHORE RH 40 * 
ETHANOL 
0.5 1.0 0.5 0.2245 0.6680 
MODEL CHECK      
LINEAR 1108.5 3.0 369.5 165.8980 0.0008 
INTERACTION 2 4.5 3.0 1.5 0.6735 0.6234 
INTERACTION 3 0.5 1.0 0.5 0.2245 0.6680 
LACK OF FIT      
LACK OF FIT 6.6818 1.0 6.6818   
PURE ERROR 0 2.0 0   
ERROR 6.6818 3.0 2.2273   
QUALITY      
METHOD USED FULL FACTORIAL DESIGN 
R2 0.9940     
ADJUSTED R2 0.9801     
PREDICTED R2  -0.4050     
S 1.4924     
MEAN 22.7273     
C.V IN % 6.5666     
PREDICTED SS 573.88     
SS= SUM OF SQUARES; DF= DEGREE OF FREEDOM; MS= MEAN SQUARED; 
 
The actual and predicted plots fall close to the line. ANOVA (partial sum squares-type-III) 
reveals the model with F ratio of 71.4198, and R2 value of 0.9940 which implies the model to 
be significant. The optimized batch as given by the analysis of the results of DoE is ScoS 
ratio of 2:1 and Oil: ScoS ratio of 1:1. 
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Thermodynamic stability studies 
Table no 5: Thermodyanamic Stability studies 
FORMULATION THERMODYNAMIC STABILITY STUDIES 
CENTRIFUGATION HEATING & COOLING 
CYCLE 
FREEZE THAW 
CYCLE 
A Pass Pass Pass 
B Pass Pass Pass 
C Pass Pass Pass 
 
 Thermodynamic stability studies differentiate those nanoemulsion formulations from 
those of kinetically stable formulations which undergo phase separation. The formulations 
which pass the thermodynamic stability studies are those formulations which contain 
adequate amounts of ScoS concentration required for nanoemulsion formulation, and which 
decreases the energy required for nanoemulsion formation. This decreased energy contributes 
to the stability of nanoemulsion. From table 5 it is evident that the formulation A, B, C passed 
the stability studies. Hence formulations A, B, C were kinetically stable with adequate 
amounts of SCoS concentration. 
 
Evaluation of nanoemulgel 
Viscosity and homogeneity studies 
Table 6: Viscosity and homogeneity studies 
FORMULATION  MEAN VISCOSITY (CP) HOMOGENEITY 
A 119.86 Clear & translucent 
B 119.28 Clear & translucent 
C 120.05 Clear & translucent 
 
The viscosities of the formulations A, B, and C were not higher, which indicates that 
the rate of drug permeation from the NG formulation is not hindered by the gel structure of 
the gelling agent and they also have good spreadability on the surface of the skin.. Moreover 
the concentration of SCoS and the oil did not oppose for the flow and hence the viscosity. 
This adds and additional advantage to the NE formulation. The formulations were found to be 
clear and translucent. 
 
Ex-vivo drug permeation through rat skin using Franz diffusion cell 
From the drug permeation studies it was observed that butenafine concentration 
steadily increased in the receptor chamber with increase in time, where the permeation profile 
generally followed Fick’s law of diffusion. The amount of butenafine that permeated through 
the skin by the end of 9hrs after application was found to be 51.19 mg, 50.28 mg, 50.64 mg 
and 44.84 mg from formulation A, B, C and M.C respectively. This may be attributed to the 
smaller globule size of the NE formulation which provides larger area for permeation of drug 
in to skin and high drug concentration on the affected area results in a larger concentration 
gradient, which is necessary for efficient dermal drug delivery. The increase in drug 
concentration in the receptor compartment may also be due to the decreased interfacial 
tension by SCoS, which is responsible for the decreased globule size. The presence of 
triglyceride in the formulation also might have accounted for the permeation. Since the basic 
nature of stratum corneum is lipid and the lipophilic nature of the NE droplets are responsible 
for loosening of the structure of stratum corneum instead of rupturing it, which is the case 
with other permeation enhancers.  
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FIG 7: Ex-vivo drug permeation studies 
 
The amount of drug that retained in the skin was found to be 30.33, 31.52, 30.86 and 
19.78 for formulation A, B, C, and marketed cream respectively. This indicated that the 
nanoemulgel formulation is more permeable through skin and is retained in the skin more 
effectively due to less globule size and viscosity when compared to the marketed cream 
formulation.  
 
In vivo treatment of infected rat skin: 
Symptoms of erythematous lesions around 20mm diameter were observed on the 5th 
day of infection. Treatment of these bloody lesions was initiated on the 8th day of infection 
which continued for 14 days. The lesions and the wounds started to cure from the 3rd day of 
treatment. By the end of 11th day of treatment there were no visually observed symptoms. 
Animals treated with marketed cream, were cured after 16 days of treatment.  This may be 
attributed to the fact that the nanoemulgel formulations has less globule size, decreased 
interfacial tension and high lipophilicity which allows high concentrations of drug to 
penetrate the skin and is effectively retained in the layers of the skin. Due to sufficient 
quantity of drug in the aqueous bed of the skin which the MC formulation could not reach, 
while the NG could because of its decreased globule size and lipophilic nature, the drug 
effectively inhibits the synthesis of ergosterol by inhibiting squalene epoxidase, an enzyme 
responsible for the creation of sterols needed in fungal cell membranes. Lacking ergosterol, 
the cell membranes increase in permeability, allowing their contents to leak out. 
 
Conclusion 
NG formulation of Butenafine Hcl was formulated by the use of DoE with optimized 
concentrations of oil phase, and SCoS. Pseudo ternary phase diagrams were constructed from 
which the levels of oil, surfactant and co surfactant at which NE is formed was obtained. The 
optimized concentration of NE formulation was derived by the use of DoE, and analyzing the 
results of DoE. The actual and predicted plots fall close to one another. ANOVA (partial sum 
squares-type-III) reveals the model to be significant with F-ratio 71.4198 and R2 value 
0.9940. The optimized formulations were thermodynamically stable, with good spreadability 
and were homogeneous. From the ex-vivo skin permeation studies it can be concluded that 
the NG formulation was more permeable through skin and was retained in the skin more 
effectively than the MC formulation due to less decreased interfacial tension, hence 
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decreased globule size and viscosity when compared to the MC formulation. From In-vivo 
treatment of infected skin studies it can be concluded that the NG formulation effectively 
treats the fungal infection when compared to the MC formulation. 
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